U.S. Close Mixed After Moving To The Upside In Early Trading

U.S. equities closed mixed on Thursday, with the Nasdaq gaining 0.4% while the S&P 500 and Dow declined 0.1% and 0.5% respectively, as early strength from President Trump's 100% semiconductor tariff announcement (exempting U.S. builders) and Apple's $100 billion investment commitment (AAPL +3.2%) was offset by broader trade policy anxieties and Intel's 3.0% drop following Trump's call for its CEO to resign. Economic data showed an unexpected rise in jobless claims to 226,000, while the pharmaceutical sector, notably Eli Lilly's 14.1% plunge on disappointing obesity pill trial results, pressured the market, and the 10-year Treasury yield climbed to 4.244%.

Analysis

U.S. equity markets closed with a notable divergence, as the tech-heavy Nasdaq advanced 0.4% while the Dow and S&P 500 retreated 0.5% and 0.1% respectively. The session was defined by a sharp, policy-driven bifurcation in the technology sector. An initial market rally was spurred by a presidential announcement of a 100% tariff on imported semiconductors, with a critical exemption for companies investing in U.S. manufacturing. This directly benefited Apple (AAPL), which rose 3.2% after confirming a new $100 billion domestic investment. However, this optimism was counteracted by a 3.0% decline in Intel (INTC) shares after the President publicly called for its CEO's resignation, injecting significant political risk into the stock. Broader market sentiment soured as concerns over the wider economic impact of new tariffs took hold, exacerbated by a higher-than-expected rise in initial jobless claims to 226,000. Sector performance was also highly dispersed; while hardware and semiconductor stocks gained, the pharmaceutical sector experienced a substantial 2.1% drop, led by a 14.1% plunge in Eli Lilly (LLY) due to disappointing obesity pill trial results, which overshadowed its strong earnings and guidance. The bond market reflected rising caution, with the 10-year Treasury yield climbing 2.4 basis points to 4.244%.

Key Decisions for Investors

• Re-evaluate semiconductor and tech hardware holdings based on their U.S. manufacturing footprint, as the new tariff structure creates a clear advantage for domestic producers or companies like Apple with committed domestic investments.
• The sharp sell-off in Intel following a presidential comment highlights the acute political risk facing corporate leadership in strategic sectors; this factor should be actively monitored as it can immediately override fundamental analysis.
• For pharmaceutical holdings, recognize that clinical trial outcomes, as seen with Eli Lilly's 14.1% drop, can be a more powerful catalyst than strong quarterly earnings, warranting a heavier focus on pipeline developments.
• Given the mixed market signals, rising jobless claims, and increasing bond yields, a cautious stance on broad market exposure is prudent, with a focus on identifying specific companies positioned to benefit from policy shifts rather than making large directional market bets.